Prostate-Specific Antigen Test for Prostate Cancer Screening: American Society of Clinical Oncology Provisional Clinical Opinion-Reference-Cited by-同舟云学术

Prostate-Specific Antigen Test for Prostate Cancer Screening: American Society of Clinical Oncology Provisional Clinical Opinion

Published:2012-09 Issue:5 Volume:8 Page:315-317
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Nam Robert K.¹,Oliver Thomas K.¹,Vickers Andrew J.¹,Thompson Ian¹,Kantoff Philip W.¹,Parnes Howard L.¹,Loblaw Andrew¹,Roth Bruce J.¹,Williams Jim¹,Temin Sarah¹,Basch Ethan¹

Affiliation:

1. Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; American Society of Clinical Oncology, Alexandria, VA; Memorial Sloan-Kettering Cancer Center, New York, NY; The University of Texas Health Science Center at San Antonio, San Antonio, TX; Harvard Medical School–Dana-Farber Cancer Institute, Boston, MA; National Cancer Institute, Rockville, MD; Washington University in St Louis, St Louis, MO; and Pennsylvania Prostate Cancer Coalition, Camp Hill, PA

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JOP.2012.000715

Reference16 articles.

1. Cancer Statistics, 2003

2. Cancer statistics, 2012

3. Prostate-Cancer Mortality at 11 Years of Follow-up

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study;World Journal of Urology;2024-04-06

2. Expected impact of MRI-targeted biopsy interreader variability among uropathologists on ProScreen prostate cancer screening trial: a pre-trial validation study;2023-08-10

3. Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial;PharmacoEconomics;2022-10-06

4. Response to Comment on Delphi Analysis of Relevant Comparators in a Cost-Effectiveness Model of Prostate Cancer Screening;PharmacoEconomics;2021-07-17

5. Using a Modified Delphi Approach to Gain Consensus on Relevant Comparators in a Cost-Effectiveness Model: Application to Prostate Cancer Screening;PharmacoEconomics;2021-04-02